The Bonnie J. Addario Lung Cancer Foundation
The Lung Cancer Foundation's

LungBlog

An up-to-the-minute dose of health and hope for lung cancer

Bonnie Addario in UCSF Lab
 

Archive for October, 2007

Women urged to beware of lung cancer risks

no smoking.jpgLaunching a new campaign to mark Lung Cancer Awareness Month today, the Irish Cancer Society said research had found that cigarettes pose a greater risk of lung cancer in women than in men.

 

No Comments | Trackback | Permalink

 

Therapy may cut lung cancer risk

cig.jpgTreatment with a derivative of vitamin A called retinoic acid may help to cut former smokers’ risk of lung cancer, research suggests.

 

No Comments | Trackback | Permalink

 

Quality of Life Predicts Lung Cancer Survival

lungs.jpgQuality of life is the most important predictor of survival for patients with locally advanced non-small cell lung cancer, U.S. researchers report.

 

1 Comment | Trackback | Permalink

 

Virus Shows Some Cancer-Killing Abilities

virus.jpgReporting in the Nov. 7 issue of Journal of the National Cancer Institute, researchers explained that the virus, Seneca Valley Virus-001 (SVV-001), was effective in treating lines of cells from small-cell lung cancer and some pediatric cancers, as well as lung cancer and eye cancer in immune-deficient mice.

 

No Comments | Trackback | Permalink

 

Alfacell’s Onconase shows promise as radiation sensitizer for lung cancer treatment

lungs.jpgCo announces that Intae Lee with the University of Pennsylvania has reported that Alfacell’s Onconase could be a promising radiation sensitizer for lung cancer treatment. Lee presented the pre- clinical in vivo data at the American Society for Therapeutic Radiology and Oncology 49th Annual Meeting. Lee provided pre-clinical evidence that Onconase significantly increased the radiation-induced tumor growth delay of lung tumors in vivo without increases in skin reaction compared to radiation alone.

 

No Comments | Trackback | Permalink

 

Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development

drug trial.jpgPfizer is currently investigating PF-3512676 in combination with non-cytotoxic anti-cancer agents. A Phase II clinical trial evaluating PF-3512676 in combination with Tarceva(R) for the treatment of refractory non-small cell lung cancer, and a Phase I clinical trial evaluating PF-3512676 in combination with Pfizer’s anti-CTLA4 antibody, tremelimumab, for the treatment of advanced melanoma are both underway. Pfizer is currently planning additional clinical trials with PF-3512676 to evaluate its safety and potential efficacy in other cancer indications.

 

No Comments | Trackback | Permalink

 

Early lung screening detects cancer before symptoms appear

CT of lung.gifEarly screening for lung cancer using non-invasive, low-dose CT scanning detects early stage cancers long before symptoms ever appear

 

No Comments | Trackback | Permalink

 

Porter Wagoner dies of lung cancer

porter wagner.jpgCountry star Porter Wagoner, 80, died tonight at 8:25 at Alive Hospice in Nashville after being diagnosed with lung cancer earlier this month.

 

No Comments | Trackback | Permalink

 

Berkeley Pit microbes may help treat cancer

berkeleypit.jpgFor decades scientists believed no life could exist in one of the most toxic places in the nation, the Berkeley Pit. But that position changed when two Butte researchers discovered microbes that could treat cancer.

 

No Comments | Trackback | Permalink

 

New Radiation Cancer Therapy Improves Care, Avoids Healthy Tissue

imrt.jpgNew advancements in a radiation oncology treatment called IMRT (intensity modulated radiation therapy) are far superior to standard radiation procedures in safeguarding the healthy tissues near cancerous tumors, thus improving patient care.

 

No Comments | Trackback | Permalink